- Home
- IMCC vs BMRA Comparison
IMCC vs BMRA Comparison
Compare IMCC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- BMRA
- Stock Information
- Founded
- IMCC 1980
- BMRA 1971
- Country
- IMCC Israel
- BMRA United States
- Employees
- IMCC N/A
- BMRA N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IMCC Health Care
- BMRA Health Care
- Exchange
- IMCC Nasdaq
- BMRA Nasdaq
- Market Cap
- IMCC 5.3M
- BMRA 8.1M
- IPO Year
- IMCC N/A
- BMRA N/A
- Fundamental
- Price
- IMCC $2.48
- BMRA $3.09
- Analyst Decision
- IMCC
- BMRA
- Analyst Count
- IMCC 0
- BMRA 0
- Target Price
- IMCC N/A
- BMRA N/A
- AVG Volume (30 Days)
- IMCC 406.8K
- BMRA 26.1K
- Earning Date
- IMCC 08-13-2025
- BMRA 04-14-2025
- Dividend Yield
- IMCC N/A
- BMRA N/A
- EPS Growth
- IMCC N/A
- BMRA N/A
- EPS
- IMCC N/A
- BMRA N/A
- Revenue
- IMCC $37,894,737.00
- BMRA $5,678,000.00
- Revenue This Year
- IMCC $47.12
- BMRA N/A
- Revenue Next Year
- IMCC $12.83
- BMRA N/A
- P/E Ratio
- IMCC N/A
- BMRA N/A
- Revenue Growth
- IMCC 12.68
- BMRA 5.01
- 52 Week Low
- IMCC $1.29
- BMRA $1.93
- 52 Week High
- IMCC $7.12
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- IMCC 47.67
- BMRA 45.39
- Support Level
- IMCC $2.67
- BMRA $3.03
- Resistance Level
- IMCC $3.35
- BMRA $3.44
- Average True Range (ATR)
- IMCC 0.40
- BMRA 0.19
- MACD
- IMCC -0.07
- BMRA 0.01
- Stochastic Oscillator
- IMCC 21.90
- BMRA 43.24
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.